4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-20-030696
Options or other derivatives
- Senior VP - Drug Discovery acquired 17,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Babu Yarlagadda S · Senior VP - Drug Discovery
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-03 | Grant or award : show line 1 in the form Emp. Stock Option (Right to Buy) | +17,000 | 17,000 | D |
Loading xslF345X03/form4.xml…